SLDB
Solid Biosciences LLC
7.30$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Solid Biosciences LLC (SLDB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -53 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 15 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.2 | -5.6 | -10 | -9.6 | -9.4 | -14 | -17 | -16 | -15 | -21 | -26 | -26 | -19 | -21 | -29 | -13 | -16 | 1.3 | -21 | -17 | -18 | -21 | -27 | -16 | -20 | -34 | -28 | -27 | -18 | -21 | -25 | -21 | -24 | -30 | -32 | -37 | -33 | -54 | -47 | -53 | -187 | |
| 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.5 | 0.5 | 0.6 | 0.7 | 0.8 | 0.8 | 1.0 | 1.3 | 0.8 | 0.8 | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.7 | 0.4 | 0.5 | 1.1 | 0.7 | 0.6 | 0.6 | 0.3 | 1.2 | 0.4 | 0.5 | 0.4 | -0.5 | 0.4 | 0.0 | -0.6 | 0.4 | 0.1 | |
| – | 0.3 | 3.2 | 0.5 | 0.8 | 0.8 | 0.8 | 1.3 | 1.8 | 2.0 | 3.5 | 3.9 | 3.4 | 3.4 | 3.1 | 3.2 | 2.8 | 2.5 | 2.9 | 3.6 | 3.4 | 3.4 | 2.6 | 1.8 | 1.5 | 1.6 | 2.1 | 1.9 | 1.6 | 1.9 | 1.6 | 2.1 | 3.0 | 3.8 | 3.3 | 3.1 | 3.9 | 6.5 | 5.2 | 5.6 | 21 | |
| 0.6 | -1.4 | 2.3 | 0.5 | – | 4.0 | 0.8 | 1.3 | 1.8 | 2.0 | 3.5 | 3.9 | 3.4 | 3.4 | 3.1 | 3.2 | 2.8 | 2.5 | 2.9 | 3.6 | 3.4 | 3.5 | 3.0 | 1.7 | 1.5 | 1.9 | 2.1 | 1.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 2.4 | 0.3 | 1.1 | 3.0 | 0.0 | -2.3 | 0.1 | 1.4 | -2.0 | -0.3 | -4.3 | 5.9 | 6.4 | -6.7 | 1.3 | 2.2 | 19 | -8.1 | -2.8 | -5.1 | -7.0 | -5.6 | 6.8 | -2.0 | -2.9 | -0.9 | -6.7 | 1.2 | -1.9 | -2.2 | 0.1 | 2.8 | 2.1 | 1.8 | -2.5 | 7.2 | -13 | 2.3 | -2.8 | -6.5 | |
| 0.4 | 0.2 | 0.2 | 0.0 | 1.7 | 0.3 | 1.0 | 3.2 | 2.1 | 1.4 | 2.0 | 1.1 | 0.7 | 0.6 | 0.7 | 0.1 | 0.1 | 0.1 | 0.0 | 0.3 | 0.2 | 0.7 | 0.2 | 1.1 | 0.8 | 0.9 | 0.5 | 0.5 | 0.4 | 0.1 | 0.1 | 0.3 | 0.0 | 0.2 | 0.1 | 0.4 | 0.1 | 0.6 | 0.2 | 0.2 | 1.0 | |
| -27 | 5.6 | 7.0 | 14 | -7.3 | -2.7 | -1.6 | -2.5 | -1.4 | -21 | -6.4 | 24 | 4.0 | 2.9 | 6.4 | 0.3 | -0.1 | -0.1 | 0.0 | -49 | -73 | 30 | 38 | -60 | 15 | 66 | 37 | -48 | -25 | 45 | -38 | -5.2 | -11 | 39 | -27 | -33 | -45 | 47 | 45 | -134 | -87 | |
| – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | 134 | – | – | – | 132 | -0.2 | 0.0 | 134 | – | – | 58 | -0.3 | – | – | – | 19 | 135 | -0.2 | 0.0 | – | – | – | 0.0 | – | – | 0.1 | 0.1 | -0.2 | -4.8 | 4.8 | -5.1 | 0.0 | 0.0 | -1.7 | 0.0 | 0.0 | -13 | 13 | 0.0 | |
| 0.0 | 0.0 | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.1 | -0.1 | -0.1 | -0.1 | -0.2 | -0.2 | 0.0 | 0.0 | -0.4 | |
| 52 | 3.4 | 25 | -0.6 | -0.9 | 54 | 132 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 58 | -0.3 | -0.3 | 129 | 129 | 129 | 135 | -0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 75 | 2.6 | 2.6 | 2.6 | 0.5 | 107 | 5.0 | 3.3 | 6.9 | 190 | -1.6 | 1.2 | 5.1 | 239 | 48 | 294 | |
| 21 | 3.5 | 22 | 3.4 | -18 | 37 | 113 | -19 | -17 | -43 | -32 | -2.2 | 43 | -19 | -23 | -13 | -16 | 130 | 114 | -66 | -91 | 9.4 | 11 | -75 | -5.5 | 106 | 9.3 | -73 | -43 | 25 | 44 | -22 | -31 | 16 | 130 | -72 | -78 | -1.4 | 237 | -138 | 20 | |
| – | -5.7 | -10 | -9.6 | -11 | -14 | -18 | -20 | -17 | -23 | -28 | -27 | -20 | -22 | -30 | -13 | -16 | 1.2 | -21 | -17 | -19 | -22 | -27 | -17 | -21 | -35 | -29 | -28 | -18 | -21 | -25 | -22 | -24 | -30 | -32 | -38 | -34 | -54 | -47 | -53 | -188 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.